This Week at FDA: Bardoxalone strikes out at adcomm; Updated device consensus standards
Regulatory NewsMichael Mezher • Kari Oakes
Biologics/ biosimilars/ vaccinesCombination products/companion diagnosticsMedical DevicesNorth AmericaPharmaceuticalsRegulatory Intelligence/Policy